Search research articles
Contact Us
Filters
Showing results (11-20 of 74) with videos related to
Page
of 8
Sort By:
The Lancet. Global Health
|
October 14, 2022
Isoniazid prophylaxis: highly effective but underutilised to prevent tuberculosis in people living with HIV
Lara Vojnov, W D Francois Venter
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
October 24, 2013
Raising the CD4+ initiation threshold with our eyes wide open
W D Francois Venter, Pierre M Barker
The New England Journal of Medicine
|
April 2, 2025
Working at Cross-PURPOSEs to Ending HIV
Glenda E Gray, W D Francois Venter
The Lancet. HIV
|
April 15, 2024
More pressure on integrase strand-transfer inhibitors?
Anton L Pozniak, W D Francois Venter
Southern African Journal of HIV Medicine
|
June 9, 2023
Weight gain on dolutegravir: Association is not the same as causation
Gary Maartens, Phumla Sinxadi, W D Francois Venter
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
November 18, 2010
Home self-testing for HIV: AIDS exceptionalism gone wrong
Marlise Richter, W D Francois Venter, Andy Gray
Biochemical Pharmacology
|
October 6, 1992
Impairment of mitochondrial 5-aminolevulinic acid synthase activity in Gunn rat liver
C Celier, D Francois, C Marsac, et al.
The Lancet. HIV
|
June 10, 2022
Integrase inhibitors hand us a new HIV clinical puzzle
W D Francois Venter, Simiso Sokhela, Jeremy Nel
The New England Journal of Medicine
|
May 20, 2011
Case records of the Massachusetts General Hospital. Case 15-2011. A 19-year-old South African woman with headache, fatigue, and vaginal discharge
W D Francois Venter, Thumbi Ndung'u, Quarraisha Abdool Karim
Current HIV/AIDS Reports
|
May 2, 2015
A Political and Social History of HIV in South Africa
Nono Simelela, W D Francois Venter, Yogan Pillay, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 74) with videos related to
Sort By:
Page
of 8
The Lancet. Global Health
|
October 14, 2022
Isoniazid prophylaxis: highly effective but underutilised to prevent tuberculosis in people living with HIV
Lara Vojnov, W D Francois Venter
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
October 24, 2013
Raising the CD4+ initiation threshold with our eyes wide open
W D Francois Venter, Pierre M Barker
The New England Journal of Medicine
|
April 2, 2025
Working at Cross-PURPOSEs to Ending HIV
Glenda E Gray, W D Francois Venter
The Lancet. HIV
|
April 15, 2024
More pressure on integrase strand-transfer inhibitors?
Anton L Pozniak, W D Francois Venter
Southern African Journal of HIV Medicine
|
June 9, 2023
Weight gain on dolutegravir: Association is not the same as causation
Gary Maartens, Phumla Sinxadi, W D Francois Venter
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
November 18, 2010
Home self-testing for HIV: AIDS exceptionalism gone wrong
Marlise Richter, W D Francois Venter, Andy Gray
Biochemical Pharmacology
|
October 6, 1992
Impairment of mitochondrial 5-aminolevulinic acid synthase activity in Gunn rat liver
C Celier, D Francois, C Marsac, et al.
The Lancet. HIV
|
June 10, 2022
Integrase inhibitors hand us a new HIV clinical puzzle
W D Francois Venter, Simiso Sokhela, Jeremy Nel
The New England Journal of Medicine
|
May 20, 2011
Case records of the Massachusetts General Hospital. Case 15-2011. A 19-year-old South African woman with headache, fatigue, and vaginal discharge
W D Francois Venter, Thumbi Ndung'u, Quarraisha Abdool Karim
Current HIV/AIDS Reports
|
May 2, 2015
A Political and Social History of HIV in South Africa
Nono Simelela, W D Francois Venter, Yogan Pillay, et al.
Page
of 8